The FDA has approved Geron's stem cell trial, the first human therapeutic trial utilizing embryonic stem cells. This first trial is to determine the viability of treating spinal cord injuries. The treatment is currently termed GRNOPC1.
Update: the trial was halted in 2011 after enrolling only 4 patients due to cost concerns.
No comments:
Post a Comment